Do Fanconi anemia genes control cell response to cross-linking agents by modulating cytochrome P-450 reductase activity?

Drug Resistance Updates

Volumn 3, Issue 4, 2000, Pages 211-215

  Kruyt, Frank A E ^a   Youssoufian, Hagop ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYTOCHROME P450 REDUCTASE; FANCONI ANEMIA GROUP C PROTEIN; GENE PRODUCT; MITOMYCIN C; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; CANCER RISK; CROSS LINKING; DRUG ACTIVATION; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME REGULATION; FANCONI ANEMIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SHORT SURVEY;

EID: 0033830308     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.2000.0159     Document Type: Article

References (54)

1. Familial panmyelocytopathy, Fanconi's anemia (FA).I. Clinical aspects
2. Fanconi anemia and novel strategies for therapy
3. Molecular biology of Fanconi anemia: Implications for diagnosis and therapy
4. International Fanconi Anemia Registry: Relation of clinical symptoms to diepoxybutane sensitivity
5. Cloning of cDNAs for Fanconi's anaemia by functional complementation
6. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA
7. Positional cloning of the Fanconi anaemia group A gene. The Fanconi anaemia/breast cancer consortium
8. The Fanconi anaemia group G gene FANCG is identical with XRCC9
9. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM
10. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9
11. Evidence for at least eight Fanconi anemia genes
12. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA
13. Resistance to mitomycin C requires direct interaction between the Fanconi anemia proteins FANCA and FANCG in the nucleus through an arginine-rich domain
14. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex
15. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex
16. Molecular genetics and Fanconi anaemia: New insights into old problems
17. Is Fanconi anemia caused by a defect in the processing of DNA damage?
18. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase
19. Mitomycin C: A prototype bioreductive agent
20. The role of reductive enzymes in cancer cell resistance to mitomycin C
21. Mitomycin C-DNA adducts generated by DT-diaphorase. Revised mechanism of the enzymatic reductive activation of mitomycin C
22. Exploring the mechanistic aspects of mitomycin antibiotic bioactivation in Chinese hamster ovary cells overexpressing NADPH: Cytochrome C (P-450) reductase and DT-diaphorase
23. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases
24. Therapeutic attack of hypoxic cells of solid tumors: Presidential address
25. Current issues in the enzymology of mitomycin C metabolic activation
26. Enzymology of mitomycin C metabolic activation in tumour tissue: Implications for enzyme-directed bioreductive drug development
27. Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH: Cytochrome c (P-450) reductase
28. Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: Correlation with sensitivity to mitomycin C and EO9
29. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: Relationship to the response of lung tumor xenografts to mitomycin C
30. Relevance of DT-diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells: Differences in in vitro and in vivo systems
31. Pharmacological determinants of the antitumour activity of mitomycin C
32. Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells
33. Mitomycin resistance in mammalian cells expressing the bacterial mitomycin C resistance protein MCRA
34. The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking
35. Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia
36. Fanconi anemia mutation causes cellular susceptibility to ambient oxygen
37. In vivo accumulation of 8-hydroxy-2'-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families
38. Effect of oxidants and antioxidants on chromosomal breakage in Fanconi anemia lymphocytes
39. Suppression of cytotoxic effect of mitomycin-C by superoxide dismutase in Fanconi's anemia and dyskeratosis congenita fibroblasts
40. Partial correction of chromosome instability in Fanconi anemia by desferrioxamine
41. Overexpression of thioredoxin in Fanconi anemia fibroblasts prevents the cytotoxic and DNA damaging effect of mitomycin C and diepoxybutane
42. Antioxidant status of Fanconi anemia fibroblasts
43. Glutathione S-transferases - A review
44. Export pumps for glutathione S-conjugates
45. Glutathione-associated cisdiamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance
46. The P450 catalytic cycle and oxygenation mechanism
47. The role of oxygen metabolism for the pathological phenotype of Fanconi anemia
48. FANCG, The Fanconi anemia group G gene product interacts with cytochrome P450 2EI: Pathophysiologic implications
49. Role of reactive oxygen species in cisdichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells
50. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines
51. Redox regulation of fos and jun DNA-binding activity in vitro
52. Nuclear factor kappa B: An oxidative stress-responsive transcription factor of eukaryotic cells
53. Regulation of the transcription factors NF-kappa B and AP-1 by redox changes